Free Trial

Innovex International (INVX) 10K Form and Latest SEC Filings 2026

Innovex International logo
$26.66 -0.76 (-2.78%)
Closing price 03:59 PM Eastern
Extended Trading
$26.97 +0.32 (+1.19%)
As of 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Innovex International SEC Filings & Recent Activity

Innovex International (NYSE:INVX) has submitted 428+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Innovex International's financial statements. The most recent filing was a Form 8-K submitted on May 4, 2026.

Form 4
Innovex International, Inc. Reports Ownership Change on Apr. 22, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Innovex International Files Current Report on May. 4, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-K
Innovex International Files Annual Report on Feb. 24, 2026

The 10-K contains Innovex International's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Innovex International SEC Filing History

Browse Innovex International's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/04/2026 3:30 PM
Innovex International (1042893) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2026 5:30 PM
Innovex International (1042893) Issuer
Reddout Mark (2025761) Reporting
Form 4/A
04/22/2026 5:30 PM
Innovex International (1042893) Issuer
Reed Kendal (2025606) Reporting
Form 4/A
04/07/2026 5:30 PM
Innovex International (1042893) Issuer
Reddout Mark (2025761) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2026 5:30 PM
Innovex International (1042893) Issuer
Reed Kendal (2025606) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2026 5:30 PM
Anderson Adam (2025643) Reporting
Innovex International (1042893) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 3:30 PM
Innovex International (1042893) Filer
Form DEF 14A
03/27/2026 3:31 PM
Innovex International (1042893) Filer
Form DEFA14A
03/27/2026 3:32 PM
Innovex International (1042893) Filer
Form ARS
03/27/2026 8:52 AM
Innovex International (1042893) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/11/2026 4:05 PM
Innovex International (1042893) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2026 6:00 PM
Innovex International (1042893) Issuer
Reed Kendal (2025606) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 6:00 PM
Black Bonnie S. (1776384) Reporting
Innovex International (1042893) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 6:00 PM
Innovex International (1042893) Issuer
Reddout Mark (2025761) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 6:00 PM
Innovex International (1042893) Issuer
LOVOI JOHN (1271502) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 6:00 PM
Innovex International (1042893) Issuer
Sedita Angie (2026303) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 6:00 PM
Innovex International (1042893) Issuer
Jupp Terence Bartlett (1561494) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 6:00 PM
Anderson Adam (2025643) Reporting
Innovex International (1042893) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 6:00 PM
Fink Benjamin Matthew (1312482) Reporting
Innovex International (1042893) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 7:54 PM
Amberjack Capital Fund II, L.P. (1944811) Filed by
Innovex International (1042893) Subject
Form SCHEDULE 13D/A
02/27/2026 7:14 PM
Innovex Co-Invest Fund GP, L.P. (2026025) Reporting
INNOVEX CO-INVEST FUND, L.P. (1777512) Reporting
Innovex International (1042893) Issuer
Interval Capital Associates II, LLC (2026023) Reporting
Intervale Capital Associates III, LLC (2026022) Reporting
Intervale Capital Fund II, L.P. (1538026) Reporting
Intervale Capital Fund II-A, L.P. (1549399) Reporting
Intervale Capital Fund III, L.P. (1600328) Reporting
Intervale Capital GP II, L.P. (2026024) Reporting
Intervale Capital GP III, L.P. (2026021) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 7:14 PM
Amberjack Capital Associates II, LLC (2026029) Reporting
Amberjack Capital Fund II, L.P. (1944811) Reporting
Amberjack Capital GP II, L.P. (2026032) Reporting
Amberjack Capital Partners, L.P. (2026035) Reporting
Amberjack Management, LLC (2026020) Reporting
Innovex Co-Invest Associates, LLC (2026027) Reporting
Innovex Co-Invest Fund II GP, L.P. (2026028) Reporting
Innovex Co-Invest Fund II, L.P. (1958403) Reporting
Innovex International (1042893) Issuer
Turowsky Jason (2025157) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2026 6:00 PM
Anderson Adam (2025643) Reporting
Innovex International (1042893) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2026 4:26 PM
Innovex International (1042893) Filer
Form 424B7
02/24/2026 6:00 PM
Anderson Adam (2025643) Reporting
Innovex International (1042893) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2026 3:34 PM
Innovex International (1042893) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/23/2026 3:41 PM
Anderson Adam (2025643) Reporting
Innovex International (1042893) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2026 5:30 PM
Anderson Adam (2025643) Reporting
Innovex International (1042893) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2026 5:30 PM
Innovex International (1042893) Issuer
Reddout Mark (2025761) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2026 3:05 PM
Anderson Adam (2025643) Reporting
Innovex International (1042893) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2026 3:07 PM
Innovex International (1042893) Subject
Reddout Mark (2025761) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2025 6:00 PM
Anderson Adam (2025643) Reporting
Innovex International (1042893) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2025 6:00 PM
Innovex International (1042893) Issuer
Reed Kendal (2025606) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2025 6:00 PM
Innovex International (1042893) Issuer
Reddout Mark (2025761) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 9:57 AM
BRANDES INVESTMENT PARTNERS, LP (1015079) Filed by
Innovex International (1042893) Subject
Form SCHEDULE 13G/A
11/04/2025 4:17 PM
Innovex International (1042893) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2025 3:33 PM
Innovex International (1042893) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2025 5:00 PM
Innovex International (1042893) Issuer
Reed Kendal (2025606) Reporting
Form 4/A
09/29/2025 5:00 PM
Innovex International (1042893) Issuer
Reddout Mark (2025761) Reporting
Form 4/A
09/12/2025 4:30 PM
Anderson Adam (2025643) Reporting
Innovex International (1042893) Issuer
Form 4/A
09/10/2025 4:30 PM
Innovex International (1042893) Issuer
Reed Kendal (2025606) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025 4:30 PM
Anderson Adam (2025643) Reporting
Innovex International (1042893) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025 4:30 PM
Innovex International (1042893) Issuer
Reddout Mark (2025761) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2025 12:46 PM
Innovex International (1042893) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
06/05/2025 4:15 PM
Innovex International (1042893) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2025 12:42 PM
BRANDES INVESTMENT PARTNERS, LP (1015079) Filed by
Innovex International (1042893) Subject
Form SCHEDULE 13G/A
05/06/2025 3:31 PM
Innovex International (1042893) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Innovex International SEC Filings - Frequently Asked Questions

Innovex International (INVX) has submitted 428+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

Innovex International's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Innovex International's financial statements page.

The most recent filing was a Form 8-K submitted on May 4, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:INVX) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners